Searchable abstracts of presentations at key conferences in endocrinology

ea0007oc9 | Development and growth | BES2004

The expression of monocarboxylate transporter 8, as a specific thyroid hormone transporter in human fetal brain and placenta: the effects of intrauterine growth restriction (IUGR)

Chan S , McCabe C , Boelaert K , Visser T , Friesema E , Franklyn J , Kilby M

Intrauterine growth restriction (IUGR) is a significant cause of perinatal morbidity, in particular neurodevelopmental delay, and is associated with fetal hypothyroxinemia. Thyroid hormone is essential for the optimal development of the central nervous system (CNS) in the fetus. Transport of the active ligand triiodothyronine (T3) across the cell membrane is required for its biological effects, initiated by binding of T3 to nuclear thyroid receptors (TR). Recently, the membran...

ea0007p100 | Endocrine tumours and neoplasia | BES2004

Pituitary tumor transforming gene (PTTG) regulates downstream angiogenic genes in thyroid cells

Kim D , Boelaert K , Stratford A , Eggo M , Watkinson J , Gittoes N , Franklyn J , McCabe C

Angiogenesis is the rate-limiting step in tumour progression and metastatic spread. Both promoters and inhibitors of angiogenesis have been implicated in thyroid tumourigenesis. We have reported PTTG overexpression in thyroid and other cancers, and PTTG upregulation of the angiogenic factors FGF-2 and VEGF in vitro. To investigate whether PTTG also transactivates other downstream angiogenic effectors, we employed angiogenesis-specific cDNA arrays. Primary thyroid cells and PTT...

ea0007p105 | Endocrine tumours and neoplasia | BES2004

Imbalance between separase and securin levels in thyroid and other malignancies

Khanim F , Parmley J , Boelaert K , Stratford A , Manners A , Hodges N , McCabe C , Gittoes N , Franklyn J

Chromosomal instability (CIN) is a common feature of many malignancies including papillary and follicular thyroid cancer. During mitosis, there are multiple stages which, if dysregulated, may result in CIN. One critical stage is the regulation of sister-chromatid separation at the metaphase-anaphase transition. Three key protein complexes regulate this process: separase, cohesins and securin (also known as pituitary tumor transforming gene). In vivo, most tumours studied demon...

ea0005oc37 | Thyroid and Calcium | BES2003

Sodium-iodide (NIS) gene expression is a potential prognostic indicator for thyroid cancer and is inhibited by pituitary tumor transforming gene (PTTG)

Boelaert K , Eggo M , Gittoes N , Watkinson J , Sheppard M , Franklyn J , McCabe C

The prognosis of differentiated thyroid cancers is influenced by their ability to accumulate iodine and hence their sensitivity to ablative 131I therapy. Radioiodine concentration is mediated by the sodium-iodide symporter (NIS). We have previously identified PTTG and fibroblast growth factor-2 (FGF-2) as potential prognostic indicators for differentiated thyroid cancers. Furthermore, we demonstrated that FGF-2 reduces iodide uptake in FRTL5 cells and primary human ...

ea0005p132 | Endocrine Tumours and Neoplasia | BES2003

Pituitary tumor transforming gene upregulates its binding factor PBF in vitro

Stratford A , Khanim F , Boelaert K , Gittoes N , Franklyn J , McCabe C

PTTG has been implicated in the pathogenesis of pituitary, thyroid and other tumours. PBF was recently identified as a protein which interacts specifically with PTTG both in vitro and in vivo. PBF facilitates PTTG's nuclear localisation, and mediates its ability to transactivate basic fibroblast growth factor (FGF-2). We investigated PBF expression and function in vitro, and examined its relationship to PTTG action. Transient transfection of wild type PTTG induced a significan...

ea0003oc34 | Hormone Action | BES2002

Iodothyronine deiodinase expression in thyroid responsive fetal tissues

Chan S , Kachilele S , McCabe C , Tannahill L , Boelaert K , Gittoes N , Franklyn J , Kilby M

The critical role of thyroid hormones (TH) in normal human growth and fetal development is well recognised. The availability of tri-iodothyronine (T3) to bind to thyroid hormone receptors is determined by the local concentrations of T3, as well as the local action of deiodinase enzymes that determine conversion of T4.Quantitative real time RT-PCR was used to quantify the expression of mRNAs encoding the specific deiodinase subtypes (D1, D2 & D3) in h...

ea0003p284 | Thyroid | BES2002

Pituitary tumor transforming gene and basic fibroblast growth factor-2 - novel potential molecular indicators for thyroid cancer

Boelaert K , McCabe C , Tannahill L , Gittoes N , Eggo M , Watkinson J , Sheppard M , Franklyn J

Differentiated thyroid cancers are the commonest endocrine malignancies, but there are no reliable molecular markers of prognosis. Pituitary tumor transforming gene (PTTG) plays several potential roles in tumour initiation and progression, including regulating mitosis and stimulating expression of fibroblast growth factor-2 (FGF-2). PTTG expression has been identified as a potential prognostic marker in pituitary adenomas and colon carcinomas. We postulated that PTTG and FGF-2...

ea0092op-11-04 | Oral Session 11: Autoimmunity / Hyperthyroidism | ETA2023

Comparison of long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: egret study

Torlinska Barbara , Hazlehurst Jonathan , Nirantharakumar Krishnarajah , Neil Thomas G. , Abrams Keith , Boelaert Kristien

Objectives: Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. Current evidence indicates differential cardio-metabolic effects from antithyroid drugs (ATD) and definitive treatment options (radioiodine or thyroidectomy). We aimed to assess differences in mortality and cardiometabolic outcomes depending on treatment modality to better inform patient-clinician decision-making.Methods: We identified...

ea0077oc2.2 | Endocrine Cancer and Late Effects | SFEBES2021

An emerging role for proteostasis modulators targeting NIS activity to enhance radioiodide therapy in thyroid cancer

Read Martin , Brookes Katie , Thornton Caitlin , Nieto Hannah , Zha Ling , Fletcher Alice , Boelaert Kristien , Smith Vicki , McCabe Christopher

Introduction: New therapeutic strategies are urgently needed to improve radioiodide (RAI) uptake and efficiently ablate thyroid cancer cells, thereby reducing the risk of recurrent disease. We recently utilised high throughput screening and identified FDA-approved compounds capable of inducing sodium iodide symporter (NIS) function to enhance iodide uptake. Categorisation revealed a high proportion of drugs that modulate proteostasis, with 6 of the top 15 targeting activity of...

ea0086op1.2 | Thyroid | SFEBES2022

Long-term mortality and cardiometabolic effects of treatment for hyperthyroidism: EGRET study

Torlinska Barbara , Hazlehurst Jonathan M. , Nirantharakumar Krishnarajah , Neil Thomas G. , Priestley Julia , Abrams Keith R. , Boelaert Kristien

Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. We aimed to assess differences in mortality and cardiometabolic outcomes depending on treatment modality to better inform patient-clinician decision-making.Methods: We identified 62,474 patients with newly diagnosed hyperthyroidism, treated with antithyroid drugs (ATD), radioiodine or thyroidectomy from a UK population-based GP database (>16M ...